Meeting of the Healthcare Infection Control Practices Advisory Committee, 83688 [2024-23896]
Download as PDF
<![CDATA[
83688
Federal Register / Vol. 89, No. 201 / Thursday, October 17, 2024 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Meeting of the Healthcare Infection
Control Practices Advisory Committee
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention announces the following
meeting for the Healthcare Infection
Control Practices Advisory Committee
(HICPAC). This virtual meeting is open
to the public.
DATES: The meeting will be held on
November 14, 2024, from 9 a.m. to 5
p.m., EST, and November 15, 2024, 9
a.m. to 12 p.m., EST.
ADDRESSES: The meeting will be
webcast live via the World Wide Web.
The webcast link can be found on the
HICPAC website. https://www.cdc.gov/
hicpac/meeting.html
FOR FURTHER INFORMATION CONTACT:
Sydnee Byrd, M.P.A., Program Analyst,
HICPAC, Division of Healthcare Quality
Promotion, NCEZID, CDC, 1600 Clifton
Road NE, Mailstop H16–3, Atlanta,
Georgia 30329–4027, Telephone: (404)
718–8039; Email: hicpac@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged
with providing advice and guidance to
the Director, Division of Healthcare
Quality Promotion (DHQP), the Director,
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
the Director, CDC; and the Secretary,
Department of Health and Human
Services, regarding (1) the practice of
healthcare infection prevention and
control; (2) strategies for surveillance,
prevention, and control of infections,
antimicrobial resistance, and related
events in settings where healthcare is
provided; and (3) periodic updating of
CDC guidelines and other policy
statements regarding prevention of
healthcare-associated infections and
healthcare-related conditions.
Matters to be Considered: The agenda
will include the following updates: The
Division of Health Quality Promotion
Updates; Isolation Precautions
Guideline Workgroup; the NHSN
Neonatal Pediatric Definitions Update
and the Healthcare Personnel Guideline
Workgroup. Agenda items are subject to
change.
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
18:31 Oct 16, 2024
Jkt 265001
Public Participation
Oral Public Comment: This meeting
will include time for members of the
public to make an oral comment.
Priority will be given to individuals
who submit a request to make an oral
public comment before the meeting
according to the procedures below. All
persons interested in making an oral
public comment at the November 14–15,
2024, HICPAC meeting must submit a
request between October 15, 2024, and
October 25, 2024, at https://
www.cdc.gov/hicpac/meeting.html no
later than 5 p.m., EDT, October 25,
2024, according to the instructions
provided. If the number of persons
requesting to speak is greater than can
be reasonably accommodated during the
scheduled time, CDC will conduct a
lottery to determine the speakers for the
scheduled public comment session.
CDC staff will notify individuals
regarding their request to speak by email
by November 1, 2024.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–23896 Filed 10–16–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Meeting of the Advisory Council for the
Elimination of Tuberculosis
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC) announces the
following meeting of the Advisory
Council for the Elimination of
Tuberculosis (ACET). This meeting is
open to the public, limited only by the
number of audio and web conference
lines (1,000 lines are available). Time
SUMMARY:
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
will be available for public comment
(registration is required to provide oral
comment; see the Oral Public Comment
section below).
DATES: The meeting will be held on
December 3, 2024, from 9:30 a.m. to
4:30 p.m., EST, and December 4, 2024,
from 10 a.m. to 12 p.m., EST.
Written comments must be submitted
by November 26, 2024. Registration to
make oral comments must also be
submitted by November 26, 2024.
ADDRESSES: The public meeting will be
held virtually through Zoom.
Registration in advance is required to
attend. Please visit https://
cdc.zoomgov.com/webinar/register/WN_
1bRtm_1MRoiz83dFlQoHQQ to register.
This registration for virtual attendance
will remain open through the meeting.
Prior to the meeting, each individual
registrant will receive a registration
confirmation along with an access link
to the virtual meeting location.
FOR FURTHER INFORMATION CONTACT:
Marah Condit, M.S., Committee
Management Lead, Office of Policy,
Planning, and Partnerships, National
Center for HIV, Viral Hepatitis, STD,
and TB Prevention, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, Mailstop US8–6, Atlanta,
Georgia 30329–4027. Telephone: (404)
639–3423; Email: nchhstppolicy@
cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Advisory Council for
the Elimination of Tuberculosis is
charged with providing advice and
recommendations regarding the
elimination of tuberculosis (TB) to the
Secretary of Health and Human
Services, the Assistant Secretary for
Health, and the Director, Centers for
Disease Control and Prevention (CDC).
Specifically, the Council makes
recommendations regarding policies,
strategies, objectives, and priorities;
addresses the development and
application of new technologies;
provides guidance and review on CDC’s
Tuberculosis Prevention Research
portfolio and program priorities; and
reviews the extent to which progress has
been made toward eliminating TB.
Matters to be Considered: The agenda
will include discussions on: (1) CDC’s
National Center for HIV, Viral Hepatitis,
STD, and TB Prevention Update; (2)
CDC’s Division of Tuberculosis
Elimination Update; (3) TB in New
Arrivals; (4) CDC’s National
Tuberculosis Surveillance System and
Molecular Surveillance; (5)
Tuberculosis Epidemiologic Studies
Consortium III; (6) Think. Test. Treat TB
Campaign; (7) Laboratory Developed
Tests Workgroup Update; and (8) Drug
E:\FR\FM\17OCN1.SGM
17OCN1
]]>Agencies
[Federal Register Volume 89, Number 201 (Thursday, October 17, 2024)]
[Notices]
[Page 83688]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-23896]
[[Page 83688]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Meeting of the Healthcare Infection Control Practices Advisory
Committee
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention announces the following
meeting for the Healthcare Infection Control Practices Advisory
Committee (HICPAC). This virtual meeting is open to the public.
DATES: The meeting will be held on November 14, 2024, from 9 a.m. to 5
p.m., EST, and November 15, 2024, 9 a.m. to 12 p.m., EST.
ADDRESSES: The meeting will be webcast live via the World Wide Web. The
webcast link can be found on the HICPAC website. https://www.cdc.gov/hicpac/meeting.html
FOR FURTHER INFORMATION CONTACT: Sydnee Byrd, M.P.A., Program Analyst,
HICPAC, Division of Healthcare Quality Promotion, NCEZID, CDC, 1600
Clifton Road NE, Mailstop H16-3, Atlanta, Georgia 30329-4027,
Telephone: (404) 718-8039; Email: [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged with providing advice and
guidance to the Director, Division of Healthcare Quality Promotion
(DHQP), the Director, National Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), the Director, CDC; and the Secretary,
Department of Health and Human Services, regarding (1) the practice of
healthcare infection prevention and control; (2) strategies for
surveillance, prevention, and control of infections, antimicrobial
resistance, and related events in settings where healthcare is
provided; and (3) periodic updating of CDC guidelines and other policy
statements regarding prevention of healthcare-associated infections and
healthcare-related conditions.
Matters to be Considered: The agenda will include the following
updates: The Division of Health Quality Promotion Updates; Isolation
Precautions Guideline Workgroup; the NHSN Neonatal Pediatric
Definitions Update and the Healthcare Personnel Guideline Workgroup.
Agenda items are subject to change.
Public Participation
Oral Public Comment: This meeting will include time for members of
the public to make an oral comment. Priority will be given to
individuals who submit a request to make an oral public comment before
the meeting according to the procedures below. All persons interested
in making an oral public comment at the November 14-15, 2024, HICPAC
meeting must submit a request between October 15, 2024, and October 25,
2024, at https://www.cdc.gov/hicpac/meeting.html no later than 5 p.m.,
EDT, October 25, 2024, according to the instructions provided. If the
number of persons requesting to speak is greater than can be reasonably
accommodated during the scheduled time, CDC will conduct a lottery to
determine the speakers for the scheduled public comment session. CDC
staff will notify individuals regarding their request to speak by email
by November 1, 2024.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-23896 Filed 10-16-24; 8:45 am]
BILLING CODE 4163-18-P
